News & Events
A retinal scan technique, developed by researchers in the University’s Center for Drug Design (CDD), has the potential to detect AD in its early stages, when treatment may still be possible, and also to allow doctors to trace the progress of treatments and help the 100,000 Minnesotans with AD and their families.
The fungal disease called white-nose syndrome has killed millions of bats since it was first discovered in North America 10 years ago, but University of Minnesota scientist Christine Salomon hopes to find a treatment deep in the cold damp shafts of the Soudan Mine.
The Minnesota Department of Natural Resources first discovered White Nose Syndrome in Minnesota last year, and the disease continues to spread west. Professor Christine Salomon is a part of the team helping raise awareness about the state of bats in Minnesota. “One of the most important things we can do is protect habitat and build new habitat for bats,” Salomon said. Watch the video
The New York State Senate recently adopted a legislative resolution commending Prof. Robert Vince upon the occasion of his designation as a 2017 Inductee into the Auburn Alumni Hall of Distinction.
Researchers at the Center for Drug Design, Profs. Robert Vince, Swati More and Dr. James Beach, have devised a new concept that may allow detection of Alzheimer's disease at an early stage — early enough to give drugs a chance to work! For the first time, changes associated with early stages of the diseases were detected in live mice through color-shifts in the light reflected by the retina. This success, from work with mice predisposed to Alzheimer’s disease, paves a way for a human trial to further test this technique.
Prof Robert Vince has been awarded the Antonin Holy Memorial Award from the International Society for Antiviral Research (ISAR). PDF